The Nomination and Remuneration Committee (Compensation Committee) of the Company approved the grant on Thursday, November 12, 2026.
Key Details of ESOP Grant
- Number of Options Granted: 19,09,179 (Nineteen Lakh Nine Thousand One Hundred and Seventy-Nine) stock options
- Scheme Name: Systematix Employee Stock Option Scheme (ESOP 2025)/(Scheme)
- Exercise Price: ₹63.45 per share (Sixty-Three Rupees and Forty-Five Paise Only)
- Recipients: Eligible employees of the company
- Compliance: The scheme is in terms of SEBI (SBEB) Regulations, 2021
Exercise Terms
- The exercise period for vested options is a maximum of 4 (Four) years commencing from the date of vesting
- Vested options can be exercised at one time or at various points within the exercise period
- Separate exercise terms apply in case of separation from employment as set out in the Scheme
Current Status
- Options have not yet vested (not applicable at this stage)
- No options have been exercised yet
- No money has been realized by exercise of options
- No options have lapsed
- No variations of terms have occurred
- No subsequent changes/cancellation/exercise of such options has occurred
Financial Impact
Financial impact not quantified in the disclosure. The disclosure pertains only to the grant of options under the ESOP scheme.